Cargando…

Multitargeting Compounds: A Promising Strategy to Overcome Multi-Drug Resistant Tuberculosis

Tuberculosis is still an urgent global health problem, mainly due to the spread of multi-drug resistant M. tuberculosis strains, which lead to the need of new more efficient drugs. A strategy to overcome the problem of the resistance insurgence could be the polypharmacology approach, to develop sing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stelitano, Giovanni, Sammartino, José Camilla, Chiarelli, Laurent Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7179463/ https://www.ncbi.nlm.nih.gov/pubmed/32182964 http://dx.doi.org/10.3390/molecules25051239

Ejemplares similares

The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme
por: Ezquerra-Aznárez, José Manuel, et al.
Publicado: (2022)

Iron Acquisition and Metabolism as a Promising Target for Antimicrobials (Bottlenecks and Opportunities): Where Do We Stand?
por: Stelitano, Giovanni, et al.
Publicado: (2023)

In vitro Study of Bedaquiline Resistance in Mycobacterium tuberculosis Multi-Drug Resistant Clinical Isolates
por: Degiacomi, Giulia, et al.
Publicado: (2020)

Shedding X-ray Light on the Role of Magnesium in the Activity of Mycobacterium tuberculosis Salicylate Synthase (MbtI) for Drug Design
por: Mori, Matteo, et al.
Publicado: (2020)

Multitarget Drug Discovery for Tuberculosis and Other Infectious Diseases
por: Li, Kai, et al.
Publicado: (2014)

Albumin-based nanoparticles: a promising strategy to overcome cancer drug resistance
por: Hassanin, Islam, et al.
Publicado: (2020)

A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK
por: Chiarelli, Laurent R., et al.
Publicado: (2018)

Overcoming Mycobacterium tuberculosis Drug Resistance: Novel Medications and Repositioning Strategies
por: Sachan, Rohan Samir Kumar, et al.
Publicado: (2023)

Rivastigmine–Benzimidazole Hybrids as Promising Multitarget Metal-Modulating Compounds for Potential Treatment of Neurodegenerative Diseases
por: Vicente-Zurdo, David, et al.
Publicado: (2023)

Targeting drug‐tolerant cells: A promising strategy for overcoming acquired drug resistance in cancer cells
por: Song, Xiaohai, et al.
Publicado: (2023)

Promising Lead Compounds in the Development of Potential Clinical Drug Candidate for Drug-Resistant Tuberculosis
por: Alghamdi, Saad, et al.
Publicado: (2020)

Agomelatine: A Potential Multitarget Compound for Neurodevelopmental Disorders
por: Savino, Rosa, et al.
Publicado: (2023)

Current Landscape of Therapeutic Resistance in Lung Cancer and Promising Strategies to Overcome Resistance
por: Ashrafi, Adnin, et al.
Publicado: (2022)

Strategies to Combat Multi-Drug Resistance in Tuberculosis
por: Singh, Vinayak, et al.
Publicado: (2021)

Pharmacological Potential of Betulin as a Multitarget Compound
por: Adepoju, Feyisayo O., et al.
Publicado: (2023)

Conjugates of Tacrine with Salicylamide as Promising Multitarget Agents for Alzheimer's Disease
por: Grishchenko, Maria V., et al.
Publicado: (2022)

Phenolic Compounds as Promising Drug Candidates in Tuberculosis Therapy
por: Mazlun, Muhamad Harith, et al.
Publicado: (2019)

Multitargeted anti-infective drugs: resilience to resistance in the antimicrobial resistance era
por: Suckling, Colin J, et al.
Publicado: (2022)

Multitarget therapeutic strategies for Alzheimer’s disease
por: Ibrahim, Mostafa M., et al.
Publicado: (2019)

Decoy Nanozymes Enable Multitarget Blockade of Proinflammatory Cascades for the Treatment of Multi-Drug-Resistant Bacterial Sepsis
por: Du, Xuancheng, et al.
Publicado: (2022)

Improving Protection to Prevent Bacterial Infections: Preliminary Applications of Reverse Vaccinology against the Main Cystic Fibrosis Pathogens
por: Cocorullo, Mario, et al.
Publicado: (2023)

Overcoming PARP inhibitor resistance in ovarian cancer: what are the most promising strategies?
por: Klotz, Daniel Martin, et al.
Publicado: (2020)

Transporter and Lysosomal Mediated (Multi)drug Resistance to Tyrosine Kinase Inhibitors and Potential Strategies to Overcome Resistance
por: de Klerk, Daniel J., et al.
Publicado: (2018)

Consensus Ensemble Multitarget Neural Network Model of Anxiolytic Activity of Chemical Compounds and Its Use for Multitarget Pharmacophore Design
por: Vassiliev, Pavel M., et al.
Publicado: (2023)

Promising Anti-Mitochondrial Agents for Overcoming Acquired Drug Resistance in Multiple Myeloma
por: Innao, Vanessa, et al.
Publicado: (2021)

Harnessing Ferroptosis to Overcome Drug Resistance in Colorectal Cancer: Promising Therapeutic Approaches
por: Cheng, Xiaofei, et al.
Publicado: (2023)

Hybrid Drugs—A Strategy for Overcoming Anticancer Drug Resistance?
por: Szumilak, Marta, et al.
Publicado: (2021)

Biomarkers beyond BRCA: promising combinatorial treatment strategies in overcoming resistance to PARP inhibitors
por: Chu, Yu-Yi, et al.
Publicado: (2022)

CC Chemokine Ligand-2: A Promising Target for Overcoming Anticancer Drug Resistance
por: Shi, Zhenbo, et al.
Publicado: (2022)

A novel compound to overcome influenza drug resistance in endonuclease inhibitors
por: Ren, Yixin, et al.
Publicado: (2023)

Conjugates of Tacrine and Salicylic Acid Derivatives as New Promising Multitarget Agents for Alzheimer’s Disease
por: Makhaeva, Galina F., et al.
Publicado: (2023)

Emerging Therapeutic Strategies to Overcome Drug Resistance in Multiple Myeloma
por: Davis, Lorraine N., et al.
Publicado: (2021)

Development of Antibiofilm Therapeutics Strategies to Overcome Antimicrobial Drug Resistance
por: Nadar, Sahaya, et al.
Publicado: (2022)

Strategies to overcome drug resistance using SHP2 inhibitors
por: Liu, Meng, et al.
Publicado: (2021)

Strategies to overcome HIV drug resistance-current and future perspectives
por: Temereanca, Aura, et al.
Publicado: (2023)

Epigenetic polypharmacology: from combination therapy to multitargeted drugs
por: de Lera, Angel R., et al.
Publicado: (2016)

Systematic Assessment of Fragment Identification for Multitarget Drug Design
por: Brunst, Steffen, et al.
Publicado: (2021)

Molecular Mechanisms of Cancer Drug Resistance: Emerging Biomarkers and Promising Targets to Overcome Tumor Progression
por: Fontana, Fabrizio, et al.
Publicado: (2022)

Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis
por: Nguyen, Phuong Chi, et al.
Publicado: (2017)

Targeting Myeloid-Derived Suppressor Cell, a Promising Strategy to Overcome Resistance to Immune Checkpoint Inhibitors
por: Hou, Aohan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lg8ngfq5gu9uneolk3n0v2i5c7